Registration - In-house Organization

Novo Nordisk Canada Inc. / Iain Graham, General Manager

Registration Information

In-house Organization name: Novo Nordisk Canada Inc.
Responsible Officer Name: Iain Graham, General Manager
Responsible Officer Change History
Initial registration start date: 2017-09-13
Registration status: Active
Registration Number: 963537-360616

Associated Communications

Total Number of Communication Reports: 140

Monthly communication reports in the last 6 months: 11

Version 24 of 25 (2026-02-02 to 2026-03-24)

Registration versions:

Version 24 of 25 (2026-02-02 to 2026-03-24)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Health, Research and Development	Advocate for the establishment of public-private partnerships to support chronic disease prevention.	Policies or Program
Health	Advocate for the implementation of a federal diabetes and obesity strategy.	Policies or Program
Health	Bill C-64, the Pharmacare Act, with respect to definitional questions related to terms contained in Section 6.1, and concerns regarding the increased risk of drug shortages.	Legislative Proposal, Bill or Resolution
Health, Research and Development, Science and Technology	Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry.	Policies or Program
Health, International Trade	Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.	Policies or Program
Health, International Trade	Free trade agreements as they relate to the biopharmaceutical industry.	Policies or Program
Health	Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.	Policies or Program

Subject matter details added through monthly communication reports
Subject matters	Details	Categories	Added date
Health	Advocating in support of Bill S-201, An Act respecting a national framework on sickle cell disease.	Legislative Proposal, Bill or Resolution	2026-04-15

Communication Techniques

Written communication
Oral communication

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Canada Foundation for Innovation
Canadian Heritage (PCH)
Canadian Human Rights Tribunal (CHRT)
Canadian Institutes of Health Research (CIHR)
Employment and Social Development Canada (ESDC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Intergovernmental Affairs Secretariat (IGA)
National Research Council (NRC)
Parks Canada (PC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)

In-house Organization Details

Description of the organization's activities

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Its Canadian headquarters is based in Mississauga, Ontario. Its purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk does this by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.

Responsible officer name and position during the period of this registration

Iain Graham, General Manager

Organization's membership or classes of membership

Novo Nordisk employs more than 77,000 people in 80 offices around the world, and markets its products in 170 countries.

Government funding

No government funding was received during the last completed financial year.

In-house Organization Contact Information

Address:
101-2476 Argentia Road
Mississauga, ON L5N 6M1
Canada

Telephone number: 905-629-4222

Lobbyists Details

Employees who lobby for the organization

Gabrielle Berard, Director, External Affairs | Designated public offices held
Luka Stevanovic, External Affairs Associate Director | No public offices held
Michael Tucker, Patient Access Manager, Atlantic | No public offices held

Novo Nordisk Canada Inc.

The following names have been used on or after July 2, 2008

Name	From	To
Novo Nordisk Canada Inc.	2017-09-13	current

Novo Nordisk Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Iain Graham	2026-02-01	Current
Vince Lamanna	2023-06-01	2026-02-01
Béatrice Clerc	2019-09-19	2023-06-01
Brian Hilberdink	2017-09-13	2019-09-17

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Director of Parliamentary Affairs Parliament of Canada, Senate of Canada	August 2017 to August 2018	Not a designated office
Policy Advisor Finance Canada, Office of the Minister of Finance	October 2011 to November 2014	November 21, 2014

Date Modified:: 2026-05-11

Search and menus

Language selection

Registration - In-house Organization

Novo Nordisk Canada Inc. / Iain Graham, General Manager

Registration Information

Associated Communications

Version 24 of 25 (2026-02-02 to 2026-03-24)

Version 24 of 25 (2026-02-02 to 2026-03-24)

Subject Matter Details

Communication Techniques

Government Institutions

Description of the organization's activities

Responsible officer name and position during the period of this registration

Organization's membership or classes of membership

Government funding

In-house Organization Contact Information

Employees who lobby for the organization